Reproductive Health & Justice FOIA Request Filed for Transparency in FDA’s Mifepristone Study Procurement Process June 17, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request was submitted on June 9, 2026, to the Food and Drug Administration (FDA) seeking detailed information concerning the solicitation and contract award processes…
